Literature DB >> 916044

Idiopathic regression of metastases from renal cell carcinoma.

S Z Freed, J P Halperin, M Gordon.   

Abstract

Herein we review 48 acceptable cases of idiopathic regression of metastases from renal cell carcinoma culled from the literature and present 3 additional cases. The data are analyzed and the issue of organ specificity in coping with metastases is discussed.

Entities:  

Mesh：

Year:  1977        PMID： 916044     DOI： 10.1016/s0022-5347(17)58099-4

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  16 in total

1.  Recycled addition of CD4+ T cell-rich population for induction of human autologous cytotoxic T lymphocytes: A practically efficient method.

Authors:  K Saijo; H Tsurushima; K Tsuboi; T Nose; A Oki; T Ohno
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

2.  New surgical horizons: the role of cytoreductive nephrectomy for metastatic kidney cancer.

Authors:  Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

Review 3.  Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy.

Authors:  M Hernberg
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

Review 4.  Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience.

Authors:  Alessia Mennitto; Paolo Grassi; Raffaele Ratta; Elena Verzoni; Michele Prisciandaro; Giuseppe Procopio
Journal:  Ther Adv Urol       Date:  2016-07-07

5.  Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cells.

Authors:  Y Tomita; H Watanabe; H Kobayashi; T Nishiyama; S Tsuji; M Fujiwara; S Sato
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Metastatic renal cell carcinoma (RCC): spontaneous regression, long-term survival and late recurrence.

Authors:  W de Riese; K Goldenberg; E Allhoff; C Stief; R Schlick; S Liedke; U Jonas
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

7.  Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.

Authors:  A J Beniers; R J van Moorselaar; W P Peelen; F M Debruyne; J A Schalken
Journal:  Urol Res       Date:  1991

8.  Human renal cell carcinoma: establishment and characterization of a new cell line (OS-RC-2).

Authors:  T Kinouchi; T Kotake; Y Mori; T Abe
Journal:  In Vitro Cell Dev Biol       Date:  1985-04

9.  Establishment and characterization of five new human renal tumor xenografts.

Authors:  A J Beniers; W P Peelen; H E Schaafsma; J L Beck; F C Ramaekers; F M Debruyne; J A Schalken
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

10.  A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma.

Authors:  Osama E Rahma; Ed Ashtar; Ramy Ibrahim; Antoun Toubaji; Barry Gause; Vincent E Herrin; W Marston Linehan; Seth M Steinberg; Frank Grollman; George Grimes; Sarah A Bernstein; Jay A Berzofsky; Samir N Khleif
Journal:  J Transl Med       Date:  2010-01-28       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.